Device therapy in heart failure patients with chronic kidney disease

Journal of the American College of Cardiology

Volumn 58, Issue 9, 2011, Pages 889-896

  Cannizzaro, Leon A ^a   Piccini, Jonathan P ^a   Patel, Uptal D ^a   Hernandez, Adrian F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cardiac resynchronization therapy; chronic kidney disease; end stage renal disease; heart failure; implantable cardioverter defibrillators; SCD

Indexed keywords

NATRIURETIC FACTOR;

ANEMIA; ARTICLE; BLOOD VOLUME; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CHRONIC KIDNEY DISEASE; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE THERAPY; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; EVIDENCE BASED MEDICINE; GLOMERULUS FILTRATION RATE; HEART ARREST; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FIBRILLATION; HEMATOMA; HEMODIALYSIS; HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LEAD POISONING; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; RISK FACTOR; SAFETY; SECONDARY PREVENTION; SUDDEN DEATH; SURVIVAL RATE; VEIN THROMBOSIS; VENOUS CONGESTION;

EID: 84860390559     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.05.024     Document Type: Review

References (56)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. U.S. Renal Data System USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2010 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
3. J. Ezekowitz, F.A. McAlister, and K.H. Humphries The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease J Am Coll Cardiol 44 2004 1587 1592 (Pubitemid 39369790)
4. F.A. McAlister, J. Ezekowitz, M. Tonelli, and P.W. Armstrong Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 2004 1004 1009 (Pubitemid 38282853)
5. A. Kottgen, S.D. Russell, and L.R. Loehr Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study J Am Soc Nephrol 18 2007 1307 1315 (Pubitemid 46536917)
6. J.D. Harnett, R.N. Foley, G.M. Kent, P.E. Barre, D. Murray, and P.S. Parfrey Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors Kidney Int 47 1995 884 890
7. D.L. Dries, D.V. Exner, M.J. Domanski, B. Greenberg, and L.W. Stevenson The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689 (Pubitemid 30167025)
8. P. Tricoci, J.M. Allen, J.M. Kramer, R.M. Califf, and S.C. Smith Scientific evidence underlying the ACC/AHA Clinical Practice Guidelines JAMA 301 2009 831 841
9. K.V. Liang, A.W. Williams, E.L. Greene, and M.M. Redfield Acute decompensated heart failure and the cardiorenal syndrome Crit Care Med 36 2008 S75 S88
10. R.S. Bhatia, J.V. Tu, and D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269 (Pubitemid 44088349)
11. A. Nohria, V. Hasselblad, and A. Stebbins Cardiorenal interactions: insights from the ESCAPE Trial J Am Coll Cardiol 51 2008 1268 1274 (Pubitemid 351400890)
12. W. Mullens, Z. Abrahams, and G.S. Francis Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
13. K.F. Adams Jr, J.H. Patterson, and R.M. Oren Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry Am Heart J 157 2009 926 932
14. T.S. Polonsky, R.L. McClelland, and N.W. Jorgensen Coronary artery calcium score and risk classification for coronary heart disease prediction JAMA 303 2010 1610 1616
15. P.H. Pun, T.R. Smarz, E.F. Honeycutt, L.K. Shaw, S.M. Al-Khatib, and J.P. Middleton Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease Kidney Int 76 2009 652 658
16. C.W. McIntyre, J.O. Burton, and N.M. Selby Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow Clin J Am Soc Nephrol 3 2008 19 26
17. J.J.G. de Lima, M.L. Campos Vieira, and H. Ferreira Lopes Blood pressure and the risk of complex arrhythmia in renal insufficiency, hemodialysis, and renal transplant patients Am J Hypertens 12 1999 204 208 (Pubitemid 29130423)
18. E. Paoletti, C. Specchia, and G. Di Maio The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey Nephrol Dial Transplant 19 2004 1829 1834 (Pubitemid 38961395)
19. I. Goldenberg, A.J. Moss, and S. McNitt Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction Am J Cardiol 98 2006 485 490 (Pubitemid 44162874)
20. P.S. Cuculich, J.M. Sánchez, and R. Kerzner Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death Pacing Clin Electrophysiol 30 2007 207 213 (Pubitemid 46333676)
21. M.P. Turakhia, P.D. Varosy, and K. Lee Impact of renal function on survival in patients with implantable cardioverter-defibrillators Pacing Clin Electrophysiol 30 2007 377 384 (Pubitemid 46426556)
22. R. Sakhuja, M. Keebler, and T.-S. Lai Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator Am J Cardiol 103 2009 735 741
23. J. Robin, K. Weinberg, and J. Tiongson Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter- defibrillator recipients Heart Rhythm 3 2006 1196 1201 (Pubitemid 44464149)
24. S. Hiremath, S.R. Punnam, and S.S. Brar Implantable defibrillators improve survival in end-stage renal disease: results from a multi-center registry Am J Nephrol 32 2010 305 310
25. C.A. Herzog, S. Li, E.D. Weinhandl, J.W. Strief, A.J. Collins, and D.T. Gilbertson Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators Kidney Int 68 2005 818 825 (Pubitemid 43323139)
26. H. Bloom, B. Heeke, and A. Leon Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery Pacing Clin Electrophysiol 29 2006 142 145
27. A. Aggarwal, Y. Wang, J.S. Rumsfeld, J.P. Curtis, and P.A. Heidenreich Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation Heart Rhythm 6 2009 1565 1571
28. M.S. Amin, A.D. Fox, G. Kalahasty, R.K. Shepard, M.A. Wood, and K.A. Ellenbogen Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis J Cardiovasc Electrophysiol 19 2008 1275 1280
29. S.M. Al-Khatib, K.J. Anstrom, and E.L. Eisenstein Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II Ann Intern Med 142 2005 593 600 (Pubitemid 40529955)
30. M. Richardson, N. Freemantle, M.J. Calvert, J.G.F. Cleland, and L. Tavazzi Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial Eur Heart J 28 2007 1827 1834 (Pubitemid 47236653)
31. G. Boerrigter, L.C. Costello-Boerrigter, and W.T. Abraham Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate J Cardiac Failure 14 2008 539 546
32. L.A. Saxon, M.R. Bristow, and J. Boehmer Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial Circulation 114 2006 2766 2772 (Pubitemid 46018278)
33. M.R. Bristow, L. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
34. J.W.H. Fung, C.C. Szeto, and J.Y.S. Chan Prognostic value of renal function in patients with cardiac resynchronization therapy Int J Cardiol 122 2007 10 16 (Pubitemid 47503342)
35. G. Nichol, P. Kaul, E. Huszti, and J.F.P. Bridges Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure Ann Intern Med 141 2004 343 351
36. M.K. de Bie, J.C. Lekkerkerker, and B. van Dam Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Triala prospective pilot study Curr Med Res Opin 24 2008 2151 2157
37. M. Jessup, W.T. Abraham, and D.E. Casey 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
38. K. Dickstein, A. Cohen-Solal, G. Filippatos Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care medicine (ESICM) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Eur Heart J 29 2008 2388 2442
39. A.G. Stack, D.A. Molony, N.S. Rahman, A. Dosekun, and B. Murthy Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States Kidney Int 64 2003 1071 1079 (Pubitemid 37013845)
40. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.-Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
41. J. He, L.G. Ogden, L.A. Bazzano, S. Vupputuri, C. Loria, and P.K. Whelton Risk factors for congestive heart failure in US men and women: NHANES I Epidemiologic Follow-up Study Arch Intern Med 161 2001 996 1002 (Pubitemid 32295654)
42. M.G. Shlipak, L.F. Fried, and M. Cushman Cardiovascular mortality risk in chronic kidney disease JAMA 293 2005 1737 1745
43. M.K. Shamseddin, and P.S. Parfrey Sudden cardiac death in chronic kidney disease: epidemiology and prevention Nat Rev Nephrol 7 2011 145 154
44. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1584
45. D. Bansch, M. Antz, and S. Boczor Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT) Circulation 105 2002 1453 1458 (Pubitemid 34263277)
46. A. Schaechter, and A. Kadish DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Cardiac Electrophysiol Rev 7 2003 457 462
47. A.J. Moss, W.J. Hall, and D.S. Cannom Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940 (Pubitemid 26428217)
48. A.J. Moss, W. Zareba, and W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
49. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease N Engl J Med 341 1999 1882 1890
50. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
51. J.G. Cleland, J.-C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
52. A.J. Moss, W.J. Hall, and D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
53. W.T. Abraham, W.G. Fisher, and A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853 (Pubitemid 34603028)
54. J.B. Young, W.T. Abraham, and A.L. Smith Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2003 2685 2694 (Pubitemid 37430139)
55. A.S.L. Tang, G.A. Wells, and M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
56. C. Linde, W.T. Abraham, M.R. Gold, M. St. John Sutton, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843